Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
:RMD
RESEARCH TOOLSreports
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
0.38Last Year’s EPS
0.34Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Jan 30, 2025
|% Change Since: -9.16%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a generally positive sentiment, with strong financial performance, revenue growth, and product innovation. Despite some concerns about currency impacts and potential tariffs, the overall outlook remains optimistic with continued investment in R&D and strategic collaborations.Company Guidance
During the Q2 Fiscal Year 2025 earnings call, ResMed provided guidance indicating strong financial and operational performance. The company reported a 10% year-over-year increase in global revenue to $1.28 billion, with a gross margin expansion of 230 basis points to 59.2%. ResMed achieved a 29% rise in non-GAAP earnings per share, supported by disciplined investments in R&D and SG&A, which respectively accounted for 6% to 7% and 18% to 20% of revenue. The residential care software business saw an 8% revenue increase, driven by the MEDIFOX DAN software vertical. ResMed's focus on manufacturing and logistics efficiencies, alongside ongoing investments in technology, is expected to maintain gross margins within the 59% to 60% range for the second half of fiscal year 2025. The company also highlighted its strategic initiatives to leverage AI and digital health ecosystems, which are expected to drive sustainable long-term growth.Strong Revenue Growth
Global revenue growth of 10% year-over-year, driven by strong market performance across U.S., Europe, Asia, and other regions.
Device and Mask Sales
Device sales increased by 11% globally, with double-digit growth in the U.S., Canada, and Latin America. Masks and other sales also grew by 11%.
Gross Margin Expansion
Achieved 230 basis points of margin expansion in non-GAAP gross margin to 59.2% year-over-year.
Non-GAAP Earnings Increase
Non-GAAP earnings per share increased by 29% year-over-year.
Cash Flow and Liquidity
Strong cash flow from operations at $309 million and a solid liquidity position with a cash balance of $522 million.
Innovations and Collaborations
Launch of AirTouch N30i and collaboration with Apple on the Kontor Head Strap for Apple Vision Pro.
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) Earnings, Revenues Date & History
AU:RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AU:RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 30, 2025 | AU$40.41 | AU$40.09 | -0.79% |
| Oct 24, 2024 | AU$35.46 | AU$37.56 | +5.92% |
| Aug 01, 2024 | AU$32.17 | AU$31.58 | -1.83% |
| Jan 24, 2024 | AU$26.44 | AU$28.12 | +6.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) report earnings?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock?
The P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is N/A.
What is AU:RMD EPS forecast?
AU:RMD EPS forecast for the fiscal quarter 2025 (Q3) is 0.38.
---